Literature DB >> 10985705

Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy.

L L Teunissen1, N C Notermans, G H Jansen, J D Banga, H Veldman, J H Wokke.   

Abstract

For chronic idiopathic axonal polyneuropathy (CIAP), even after extensive evaluation, no cause has yet been found. Considering the age and sex distribution of patients with this disease, it is possible that vascular disease plays a role in the development of this polyneuropathy. As endoneurial vessel abnormalities can be related to ischemia, we investigated endoneurial vessels in sural nerve biopsies of 18 patients with CIAP. As controls we used sural nerves of 4 patients with diabetes mellitus, 6 patients with hereditary motor and sensory neuropathy type II (HMSN type III) and 10 autopsy cases. Basal lamina area thickness, endothelial cell area, lumen area, and the number of basal laminae, endothelial cells and periendothelial cell nuclei were investigated. Basal lamina area thickness, endoneurial cell area and number of endothelial cell nuclei in CIAP were increased in comparison with HMSN type III, whereas the basal lamina area thickness of patients with CIAP and diabetes mellitus were in the same range. The structure of the basal lamina area in CIAP differed from diabetes mellitus; in diabetes mellitus there was a larger number of lamellae, whereas in CIAP there was an increase in collagen. There was no correlation between basal lamina area thickness and age. In CIAP patients with peripheral vascular disease of the legs, basal lamina area thickness was increased. The relation between basal lamina area thickening and peripheral vascular disease of the legs in CIAP may indicate a role for ischemia in the development of this polyneuropathy.

Entities:  

Mesh:

Year:  2000        PMID: 10985705     DOI: 10.1007/s004010000193

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 2.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

3.  Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

Authors:  L L Teunissen; H Franssen; J H J Wokke; Y van der Graaf; W H J P Linssen; J D Banga; D M Laman; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

4.  Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.

Authors:  Nora A Visser; Nicolette C Notermans; Ferdinand Teding van Berkhout; Leonard H van den Berg; Alexander Fje Vrancken
Journal:  Chron Respir Dis       Date:  2016-03-15       Impact factor: 2.444

5.  Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).

Authors:  Larissa Hube; Maike F Dohrn; Gergely Karsai; Sarah Hirshman; Philip Van Damme; Jörg B Schulz; Joachim Weis; Thorsten Hornemann; Kristl G Claeys
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

6.  Diet quality and chronic axonal polyneuropathy: a population-based study.

Authors:  Noor E Taams; Trudy Voortman; Rens Hanewinckel; Judith Drenthen; Pieter A van Doorn; Mohammad A Ikram
Journal:  Ann Clin Transl Neurol       Date:  2019-11-18       Impact factor: 4.511

7.  Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.

Authors:  Nora A Visser; Alexander F J E Vrancken; Yvonne T van der Schouw; Leonard H van den Berg; Nicolette C Notermans
Journal:  Diabetes Care       Date:  2012-11-30       Impact factor: 19.112

8.  Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy.

Authors:  Kristin Samuelsson; Ayman A M Osman; Maria Angeria; Mårten Risling; Simin Mohseni; Rayomand Press
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 9.  Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.

Authors:  Kristin Samuelsson; Rayomand Press
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

10.  The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Authors:  K Kahnert; M Föhrenbach; T Lucke; P Alter; F T Trudzinski; R Bals; J I Lutter; H Timmermann; S Söhler; S Förderreuther; D Nowak; H Watz; B Waschki; J Behr; T Welte; C F Vogelmeier; R A Jörres
Journal:  Respir Res       Date:  2020-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.